Loss of Smell Reported in 86% of Mild COVID Cases
A European study found patients with mild cases of COVID-19 were much more likely to report losing their sense of smell than patients with moderate to critical cases. Almost all the patients got their...
View ArticleLong-Term Effects of COVID-19
CDC is actively working to learn more about the whole range of short- and long-term health effects associated with COVID-19. As the pandemic unfolds, we are learning that many organs besides the lungs...
View ArticleGrowing Immunity Driving Drop in COVID Cases? Not So Fast, Experts Say
After more than 3 months of record-breaking surges of COVID-19 cases and deaths in the United States, the national numbers are finally going in a welcome direction: down. Since early January — when the...
View ArticleTough Pain Relief Choices in the COVID-19 Pandemic
More people with fever and body aches are turning to nonsteroidal anti-inflammatory drugs (NSAIDs) to ease symptoms, but the drugs have come under new scrutiny as investigators work to determine...
View ArticleBreast Cancer Mortality Rates No Longer Falling for Younger Women
After more than two decades, women between ages 20 and 39 are seeing a slight increase in the rates of breast cancer mortality. The two decade-plus trend of declining death rates from breast cancer is...
View ArticleCOVID-19 Vaccine FAQ
We all want this pandemic to end. By February 2021, the COVID-19 pandemic caused 100 million confirmed infections and 2.2 million deaths worldwide. In the United States, 26 million people have been...
View ArticleScientists Call on C.D.C. to Set Air Standards for Workplaces, Now
The agency has not fully reckoned with airborne transmission of the coronavirus in settings like hospitals, schools and meatpacking plants, experts said. Nearly a year after scientists showed that the...
View ArticleCan I Have the Coronavirus Vaccine if I’ve had Breast Cancer Treatment?
With the COVID-19 vaccination programme being rolled out across the country Dr Sheeba Irshad, senior clinical lecturer, breast cancer medical oncologist and clinical deputy head of the Breast Cancer...
View ArticleI’ve Had My Covid-19 vaccine – Now What Can I Safely Do?
The day has finally come. You’ve received the second dose of a Covid-19 vaccine currently on the Western market — Moderna, Pfizer-BioNTech or Oxford-AstraZeneca. Does that mean you’re free to go about...
View ArticleNew COVID-19 Monoclonal Antibody Data Could Shift Clinical Practice
New data from phase 3 trials of monoclonal antibodies for patients with recent COVID-19 diagnoses, or at high risk for SARS-CoV-2 infection, could move the needle on clinician acceptance of the...
View Article
